Arbutus Biopharma Corp (ABUS)

EBITDA Margin

-504.34%

Quarterly · Period ending:

ABUS logo

ABUS EBITDA Margin

Latest reported-504.34%
ABUS Quarterly EBITDA Margin (10.21% → -504.34%)
High-resolution chart · PNG

ABUS ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp EBITDA Margin — Quarterly
Period endingEBITDA Margin
-504.3393%
94.7506%
-354.6147%
-1,457.0888%
23.857%
-1,370.068%
-974.2694%
-1,445.2577%
-1,124.3337%
-1,140.7311%
-939.9068%
-422.6921%
-356.504%
-236.384%
-330.6005%
-282.1741%
-93.5819%
-82.8313%
-629.32%
-537.3952%
-751.9107%
-714.8131%
-657.544%
-1,128.759%
-824.7688%
-826.2911%
-783.4981%
-3,056.2561%
-3,492.8025%
-3,347.57%
-1,050.2384%
-1,780.5923%
-1,518.2476%
-1,164.5543%
-2,350.2762%
-158.6042%
-1,704.2348%
-7,766.383%
9,786.6667%
-2,494.0568%
-6,042.7184%
-2,596.5174%
-38.4045%
-351.6605%
-409.1765%
-183.49%
-244.4598%
-153.8514%
-512.0928%
-131.4673%
-30.5722%
-118.4236%
-104.8612%
-131.0696%
-151.8897%
-51.1339%
-65.0955%
-67.1748%
-58.7347%
-34.3313%
-76.7708%
-65.3321%
-115.5439%
-21.4774%
-152.1373%
-161.635%
-44.3148%
-61.2731%
-44.5476%
-59.3622%
23.3124%
-55.3689%
-196.1555%
-38.2222%
-115.3493%
30.4515%
10.2083%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.